Eagle Pharmaceuticals, Inc. (EGRX): Price and Financial Metrics
GET POWR RATINGS... FREE!
EGRX POWR Grades
- Value is the dimension where EGRX ranks best; there it ranks ahead of 98.5% of US stocks.
- The strongest trend for EGRX is in Stability, which has been heading down over the past 177 days.
- EGRX's current lowest rank is in the Stability metric (where it is better than 3.64% of US stocks).
EGRX Stock Summary
- With a year-over-year growth in debt of 123.33%, EAGLE PHARMACEUTICALS INC's debt growth rate surpasses 89.88% of about US stocks.
- Over the past twelve months, EGRX has reported earnings growth of 612.89%, putting it ahead of 97.18% of US stocks in our set.
- Revenue growth over the past 12 months for EAGLE PHARMACEUTICALS INC comes in at 66.48%, a number that bests 86.95% of the US stocks we're tracking.
- Stocks with similar financial metrics, market capitalization, and price volatility to EAGLE PHARMACEUTICALS INC are WEAV, RCEL, APDN, BIOC, and VBIV.
- EGRX's SEC filings can be seen here. And to visit EAGLE PHARMACEUTICALS INC's official web site, go to www.eagleus.com.
EGRX Valuation Summary
- In comparison to the median Healthcare stock, EGRX's price/sales ratio is 20% lower, now standing at 1.6.
- EGRX's price/sales ratio has moved down 8.5 over the prior 107 months.
Below are key valuation metrics over time for EGRX.
EGRX Growth Metrics
- Its 5 year net income to common stockholders growth rate is now at -96.97%.
- The 2 year net cashflow from operations growth rate now stands at -96.57%.
- The 5 year revenue growth rate now stands at 1.4%.
The table below shows EGRX's growth in key financial areas (numbers in millions of US dollars).
|Date||Revenue||Operating Cash Flow||Net Income to Common Stock|
EGRX's Quality FactorsThe “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
- EGRX has a Quality Grade of B, ranking ahead of 92.42% of graded US stocks.
- EGRX's asset turnover comes in at 0.738 -- ranking 36th of 682 Pharmaceutical Products stocks.
- ACUR, XENE, and KMPH are the stocks whose asset turnover ratios are most correlated with EGRX.
The table below shows EGRX's key quality metrics over time.
|Period||Asset Turnover||Gross Margin||ROIC|
EGRX Stock Price Chart Interactive Chart >
EGRX Price/Volume Stats
|Current price||$32.72||52-week high||$56.43|
|Prev. close||$33.76||52-week low||$24.35|
|Day high||$34.29||Avg. volume||143,641|
|50-day MA||$32.21||Dividend yield||N/A|
|200-day MA||$40.17||Market Cap||425.88M|
Eagle Pharmaceuticals, Inc. (EGRX) Company Bio
Eagle Pharmaceuticals focuses on developing and commercializing injectable products primarily in the critical care and oncology areas in the United States. The company was founded in 2007 and is based in Woodcliff Lake, New Jersey.
Most Popular Stories View All
EGRX Latest News Stream
|Loading, please wait...|
EGRX Latest Social Stream
View Full EGRX Social Stream
Latest EGRX News From Around the Web
Below are the latest news stories about EAGLE PHARMACEUTICALS INC that investors may wish to consider to help them evaluate EGRX as an investment opportunity.
Eagle Pharmaceuticals’ Investor Day to Focus on Acute Care Products and Pipeline Programs; Tuesday, December 6, 2022, at 8:00am ET at the Lotte New York Palace
KOL headshot KOL headshot KOL headshot KOL headshot KOL headshot KOL headshot -- Featured speakers and KOLs include: Scott Tarriff, Herm Cukier, Dr. Richard Dutton, Dr. Prem Fort, Dr. TJ Gan, Dr. Andre Kalil, Dr. Joseph Pergolizzi and Dr. Eugene Vortsman -- -- Topics include the clinical and scientific rationale for the Company’s hospital-based products and pipeline programs: Enalare’s ENA-001, CAL02, BARHEMSYS®, BYFAVO® and landiolol -- WOODCLIFF LAKE, N.J., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Ea
Eagle Pharmaceuticals’ Investor Day to Feature World-Renowned KOLs on Tuesday, December 6, 2022, at the Lotte New York Palace Hotel
-- Featured speakers and KOLs include: Scott Tarriff, Herm Cukier, Dr. Richard Dutton, Dr. Prem Fort, Dr. TJ Gan, Dr. Andre Kalil, Dr. Joseph Pergolizzi and Dr. Eugene Vortsman -- -- Topics include the clinical and scientific rationale for the Company’s hospital-based products and pipeline programs: Enalare’s ENA-001, CAL02, BARHEMSYS®, BYFAVO® and landiolol -- WOODCLIFF LAKE, N.J., Nov. 16, 2022 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today anno
Eagle Pharmaceuticals Announces FDA Acceptance of Investigational New Drug Application for CAL02, a Novel First-in-Class Broad-Spectrum Anti-Virulence Agent for the Adjunct Treatment of Severe Community-Acquired Bacterial Pneumonia
-- Expect to begin a Phase 2 study in approximately 276 patients with severe community-acquired pneumonia at approximately 120 sites worldwide -- -- Patient enrollment expected to commence as early as the beginning of 2023 -- -- CAL02 is being developed as an adjunct to the clinically indicated antibiotic treatment -- WOODCLIFF LAKE, N.J., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) announced today that the U.S. Food and Drug Administra
WOODCLIFF LAKE, N.J., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. is re-issuing in its entirety its earnings press release for the third quarter ended September 30, 2022, originally issued on November 7, 2022 at 6:50 am ET, to correct errors in the presentation of certain line items in the financial statements included therein and corresponding references to such items in the narrative disclosure as described in the Company's Form 8-K/A filed on November 9, 2022. All other info
Industry Analysts Just Made A Substantial Upgrade To Their Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) Revenue Forecasts
Shareholders in Eagle Pharmaceuticals, Inc. ( NASDAQ:EGRX ) may be thrilled to learn that the analysts have just...
EGRX Price Returns
Continue Researching EGRXWant to do more research on Eagle Pharmaceuticals Inc's stock and its price? Try the links below:
Eagle Pharmaceuticals Inc (EGRX) Stock Price | Nasdaq
Eagle Pharmaceuticals Inc (EGRX) Stock Quote, History and News - Yahoo Finance
Eagle Pharmaceuticals Inc (EGRX) Stock Price and Basic Information | MarketWatch